Sign in

CIK 0001807120

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Design Therapeutics, Inc.

Sign in to watch
Ticker
DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823929248
Phone
+1 858-293-4900
Business address
6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 40,000 shares at $15.45 ($618,000)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Chief Operating Officer bought 3,050 shares at $20.00 ($61,000)
  9. 4 Conversion 10% owner acquired 4,720,830 shares (conversion)
  10. 4 Open-market buy 10% owner bought 250,000 shares at $20.00 ($5,000,000)
  11. 4 Open-market buy Director bought 10,000 shares at $20.00 ($200,000)
  12. 4 Open-market buy Director bought 250,000 shares at $20.00 ($5,000,000)
  13. 4 Open-market buy Director bought 5,000 shares at $20.00 ($100,000)
  14. 4 Open-market buy Executive Chairperson bought 25,000 shares at $20.00 ($500,000)
  15. 4 Open-market buy Vice President, Finance bought 17,500 shares at $20.00 ($350,000)
  16. 4 Open-market buy Director bought 700,000 shares at $20.00 ($14,000,000)
  17. 4 Open-market buy Former 10% Owner bought 750,000 shares at $20.00 ($15,000,000)
  18. 3/A Insider 3/A
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 6 · 117 filings